Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

Clinical trial NCT02460978 · COMPLETED

Trial details

NCT number: NCT02460978
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2015-07-08
Primary completion: 2017-09-02
Enrollment: 815

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.